Drug Digest: Engineering LNPs Beyond the Liver for Genetic Medicines

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Marcos Castanheira Alegria

Marcos Castanheira Alegria is R&D director at Hypera Pharma.

Articles by Marcos Castanheira Alegria

Brazilian Regulation of Biosimilar Products: What Is Important to Know

Brazilian Regulation of Biosimilar Products: What Is Important to Know

BySílvia Helena Cestari de Oliveira,Marcos Castanheira Alegria,Marco Antonio Stephano

September 1st 2022

This article introduces the requirements for a biosimilar license in Brazil and addresses questions about their quality, safety, and efficacy.

Latest Updated Articles

Brazilian Regulation of Biosimilar Products: What Is Important to Know
September 1st 2022